Literature DB >> 19216936

Modeling fatigue over sleep deprivation, circadian rhythm, and caffeine with a minimal performance inhibitor model.

Patrick L Benitez1, Gary H Kamimori, Thomas J Balkin, Alexander Greene, Michael L Johnson.   

Abstract

Sleep loss, as well as concomitant fatigue and risk, is ubiquitous in today's fast-paced society. A biomathematical model that succeeds in describing performance during extended wakefulness would have practical utility in operational environments and could help elucidate the physiological basis of sleep loss effects. Eighteen subjects (14 males, 4 females; age 25.8 +/- 4.3 years) with low levels of habitual caffeine consumption (<300 mg/day) participated. On night 1, subjects slept for 8 h (2300-0700 h), followed by 77 h of continuous wakefulness. They were assigned randomly to receive placebo or caffeine (200 mg, i.e., two sticks of Stay Alert gum) at 0100, 0300, 0500, and 0700 during nights 2, 3, and 4. The psychomotor vigilance test (PVT) was administered periodically over the 77-h period of continuous wakefulness. Statistical analysis reveals lognormality in each PVT, allowing for closed-form median calculation. An iterative parameter estimation algorithm, which takes advantage of MatLab's (R2007a) least-squares nonlinear regression, is used to estimate model parameters from subjects' PVT medians over time awake. In the model, daily periodicity is accounted for with a four-component Fourier series, and a simplified binding function describes asymptotic fatigue. The model highlights patterns in data that suggest (1) the presence of a performance inhibitor that increases and saturates over the period of continuous wakefulness, (2) competitive inhibition of this inhibitor by caffeine, (3) the persistence of an internally driven circadian rhythm of alertness, and (4) a multiplicative relationship between circadian rhythm and performance inhibition. The present inhibitor-based minimal model describes performance data in a manner consistent with known biochemical processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216936      PMCID: PMC2654588          DOI: 10.1016/S0076-6879(08)03816-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  28 in total

Review 1.  Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.

Authors:  Emmanuel Mignot; Shahrad Taheri; Seiji Nishino
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

2.  Modeling of oscillations in endocrine networks with feedback.

Authors:  Leon S Farhy
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Modulating the homeostatic process to predict performance during chronic sleep restriction.

Authors:  Michael L Johnson; Gregory Belenky; Daniel P Redmond; David R Thorne; Jason D Williams; Steven R Hursh; Thomas J Balkin
Journal:  Aviat Space Environ Med       Date:  2004-03

Review 4.  The two-process model of sleep regulation revisited.

Authors:  Peter Achermann
Journal:  Aviat Space Environ Med       Date:  2004-03

5.  The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.

Authors:  J D Veldhuis; M L Carlson; M L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 6.  Effects of caffeine on blood pressure.

Authors:  M G Myers
Journal:  Arch Intern Med       Date:  1988-05

7.  Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers.

Authors:  R Ammar; J C Song; J Kluger; C M White
Journal:  Pharmacotherapy       Date:  2001-04       Impact factor: 4.705

8.  Cardiovascular effects of coffee and caffeine.

Authors:  T L Whitsett; C V Manion; H D Christensen
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

9.  Effects of caffeine on plasma renin activity, catecholamines and blood pressure.

Authors:  D Robertson; J C Frölich; R K Carr; J T Watson; J W Hollifield; D G Shand; J A Oates
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

10.  Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.

Authors:  Paul Hewlett; Andrew Smith
Journal:  Hum Psychopharmacol       Date:  2007-08       Impact factor: 1.672

View more
  4 in total

1.  A Unified Model of Performance for Predicting the Effects of Sleep and Caffeine.

Authors:  Sridhar Ramakrishnan; Nancy J Wesensten; Gary H Kamimori; James E Moon; Thomas J Balkin; Jaques Reifman
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

2.  Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation.

Authors:  Devon A Hansen; Sridhar Ramakrishnan; Brieann C Satterfield; Nancy J Wesensten; Matthew E Layton; Jaques Reifman; Hans P A Van Dongen
Journal:  Psychopharmacology (Berl)       Date:  2018-12-11       Impact factor: 4.530

3.  iLid: Low-power Sensing of Fatigue and Drowsiness Measures on a Computational Eyeglass.

Authors:  Soha Rostaminia; Addison Mayberry; Deepak Ganesan; Benjamin Marlin; Jeremy Gummeson
Journal:  Proc ACM Interact Mob Wearable Ubiquitous Technol       Date:  2017-06

4.  Prediction of Vigilant Attention and Cognitive Performance Using Self-Reported Alertness, Circadian Phase, Hours since Awakening, and Accumulated Sleep Loss.

Authors:  Eduardo B Bermudez; Elizabeth B Klerman; Charles A Czeisler; Daniel A Cohen; James K Wyatt; Andrew J K Phillips
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.